TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 48 filers reported holding TRINITY BIOTECH PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q3 2017 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | -28.6% | 900 | -12.3% | 0.00% | – |
Q4 2016 | $7,000 | -89.6% | 1,026 | -79.6% | 0.00% | -100.0% |
Q3 2016 | $67,000 | +42.6% | 5,028 | +19.9% | 0.00% | +100.0% |
Q2 2016 | $47,000 | – | 4,195 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lyon Street Capital, LLC | 639,291 | $14,723,000,000 | 6.49% |
ACK Asset Management | 684,655 | $15,768,000 | 4.74% |
GOLDMAN CAPITAL MANAGEMENT INC | 304,690 | $7,017,000 | 3.48% |
Paradice Investment Management LLC | 239,138 | $5,507,000 | 1.64% |
Park West Asset Management LLC | 520,770 | $11,993,000 | 1.56% |
RK Capital | 323,279 | $7,445,000 | 1.48% |
Adirondack Research & Management Inc. | 184,638 | $4,252,000 | 1.44% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 861,625 | $19,843,000 | 1.07% |
Pier Capital, LLC | 251,917 | $5,802,000 | 0.82% |
Benchmark Capital Advisors | 56,954 | $1,312,000 | 0.82% |